These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3469017)

  • 1. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
    Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
    Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
    Bhalla K; Hindenburg A; Taub RN; Grant S
    Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
    Bogush T; Robert J
    Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r].
    Hu X; Chen WY
    Zhongguo Yao Li Xue Bao; 1994 May; 15(3):275-9. PubMed ID: 7976387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
    Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells.
    Hindenburg AA; Gervasoni JE; Krishna S; Stewart VJ; Rosado M; Lutzky J; Bhalla K; Baker MA; Taub RN
    Cancer Res; 1989 Aug; 49(16):4607-14. PubMed ID: 2545346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics.
    Tsuruo T
    Cancer Treat Rep; 1983 Oct; 67(10):889-94. PubMed ID: 6354436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular pharmacology of anthracycline resistance and its circumvention.
    Tapiero H; Fourcade A; Munck JN; Zwingelstein G; Lampidis TJ
    Drugs Exp Clin Res; 1986; 12(1-3):265-73. PubMed ID: 3460753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.
    Sweet P; Chan PK; Slater LM
    Cancer Res; 1989 Feb; 49(3):677-80. PubMed ID: 2910487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
    Urasaki Y; Ueda T; Yoshida A; Fukushima T; Takeuchi N; Tsuruo T; Nakamura T
    Anticancer Res; 1996; 16(2):709-14. PubMed ID: 8687117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug.
    Marsh W; Sicheri D; Center MS
    Cancer Res; 1986 Aug; 46(8):4053-7. PubMed ID: 2425939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells.
    Klohs WD; Steinkampf RW
    Mol Pharmacol; 1988 Aug; 34(2):180-5. PubMed ID: 2901030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical mechanism for resistance to anthracycline antibiotics.
    Inaba M
    Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents.
    Schwartz HS; Kanter PM
    Cancer Treat Rep; 1979 May; 63(5):821-5. PubMed ID: 287555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
    Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A
    Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
    Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI
    Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies on anthracycline haloderivatives.
    Facchinetti T; Geroni C; Fumagalli A; Giuliani FC
    Drugs Exp Clin Res; 1986; 12(8):657-61. PubMed ID: 3463498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H; Nguyen-Ba G; Lampidis TJ
    Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.